MindMed is a clinical-stage biopharmaceutical company that discovers, develops, and deploys psychedelic-inspired medicines and therapies to address addiction and mental illness.
Encoded Therapeutics is a biotechnology company focused on developing transformative gene therapies for CNS disorders.
Acadia Pharmaceuticals is dedicated to pioneering innovative therapies for neurological disorders, focusing on elevating the lives of patients through dedicated research and community support.
STSage Therapeutics is a biopharmaceutical company focused on developing and commercializing novel medicines for brain health disorders, including postpartum depression.
BBBeacon Biosignals leverages innovative EEG technology to drive precision medicine in neurology and psychiatry, aiming to improve patient outcomes through advanced analytics.
BMBlueprint Medicines is a leading biopharmaceutical company dedicated to developing transformative therapies for patients with serious diseases.